Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucía Trilla-Fuertes

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Analytical Chemistry|March 19, 2019
Isotopologue Multipoint Calibration for Proteomics Biomarker Quantification in Clinical PracticeCristina Chiva, Olga Pastor, Lucía Trilla-Fuertes, et al.
Future Oncology (London, England)|October 4, 2019
Computational metabolism modeling predicts risk of distant relapse-free survival in breast cancer patientsLucía Trilla-Fuertes, Angelo Gámez-Pozo, Mariana Díaz-Almirón, et al.
Ultrasonography (Seoul, Korea)|March 9, 2026
Monitoring of low-risk pancreatic cystic lesions with targeted abdominal ultrasound: diagnostic yield, clinical utility, and acceptanceEva Marín Serrano, Laura Tello Arnas, Ángelo Gámez-Pozo, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 26, 2022
Synergistic effect of antimetabolic and chemotherapy drugs in triple-negative breast cancerElena López-Camacho, Lucía Trilla-Fuertes, Angelo Gámez-Pozo, et al.
Oncotarget|July 3, 2018
Probabilistic graphical models relate immune status with response to neoadjuvant chemotherapy in breast cancerAndrea Zapater-Moros, Angelo Gámez-Pozo, Guillermo Prado-Vázquez, et al.
Metabolomics : Official Journal of the Metabolomic Society|June 21, 2023
Metabolomics unravels subtype-specific characteristics related to neoadjuvant therapy response in breast cancer patientsAndrea Zapater-Moros, Leticia Díaz-Beltrán, Angelo Gámez-Pozo, et al.
BMC Cancer|June 30, 2019
Biological molecular layer classification of muscle-invasive bladder cancer opens new treatment opportunitiesLucía Trilla-Fuertes, Angelo Gámez-Pozo, Guillermo Prado-Vázquez, et al.
Cancers|February 25, 2023
A Novel Molecular Analysis Approach in Colorectal Cancer Suggests New Treatment OpportunitiesElena López-Camacho, Guillermo Prado-Vázquez, Daniel Martínez-Pérez, et al.
Plos One|June 9, 2017
Prediction of adjuvant chemotherapy response in triple negative breast cancer with discovery and targeted proteomicsAngelo Gámez-Pozo, Lucía Trilla-Fuertes, Guillermo Prado-Vázquez, et al.
Biomedicines|February 25, 2023
The Relationship between the Expression of GATA4 and GATA6 with the Clinical Characteristics and Prognosis of Resectable Pancreatic AdenocarcinomaVictoria Heredia-Soto, Laura Gutiérrez-Sainz, Ismael Ghanem, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Analytical Chemistry|March 19, 2019
Isotopologue Multipoint Calibration for Proteomics Biomarker Quantification in Clinical PracticeCristina Chiva, Olga Pastor, Lucía Trilla-Fuertes, et al.
Future Oncology (London, England)|October 4, 2019
Computational metabolism modeling predicts risk of distant relapse-free survival in breast cancer patientsLucía Trilla-Fuertes, Angelo Gámez-Pozo, Mariana Díaz-Almirón, et al.
Ultrasonography (Seoul, Korea)|March 9, 2026
Monitoring of low-risk pancreatic cystic lesions with targeted abdominal ultrasound: diagnostic yield, clinical utility, and acceptanceEva Marín Serrano, Laura Tello Arnas, Ángelo Gámez-Pozo, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 26, 2022
Synergistic effect of antimetabolic and chemotherapy drugs in triple-negative breast cancerElena López-Camacho, Lucía Trilla-Fuertes, Angelo Gámez-Pozo, et al.
Oncotarget|July 3, 2018
Probabilistic graphical models relate immune status with response to neoadjuvant chemotherapy in breast cancerAndrea Zapater-Moros, Angelo Gámez-Pozo, Guillermo Prado-Vázquez, et al.
Metabolomics : Official Journal of the Metabolomic Society|June 21, 2023
Metabolomics unravels subtype-specific characteristics related to neoadjuvant therapy response in breast cancer patientsAndrea Zapater-Moros, Leticia Díaz-Beltrán, Angelo Gámez-Pozo, et al.
BMC Cancer|June 30, 2019
Biological molecular layer classification of muscle-invasive bladder cancer opens new treatment opportunitiesLucía Trilla-Fuertes, Angelo Gámez-Pozo, Guillermo Prado-Vázquez, et al.
Cancers|February 25, 2023
A Novel Molecular Analysis Approach in Colorectal Cancer Suggests New Treatment OpportunitiesElena López-Camacho, Guillermo Prado-Vázquez, Daniel Martínez-Pérez, et al.
Plos One|June 9, 2017
Prediction of adjuvant chemotherapy response in triple negative breast cancer with discovery and targeted proteomicsAngelo Gámez-Pozo, Lucía Trilla-Fuertes, Guillermo Prado-Vázquez, et al.
Biomedicines|February 25, 2023
The Relationship between the Expression of GATA4 and GATA6 with the Clinical Characteristics and Prognosis of Resectable Pancreatic AdenocarcinomaVictoria Heredia-Soto, Laura Gutiérrez-Sainz, Ismael Ghanem, et al.
Pageof 4